185 related articles for article (PubMed ID: 11242610)
1. Nephrogenic diabetes insipidus persisting 57 months after cessation of lithium carbonate therapy: report of a case and review of the literature.
Guirguis AF; Taylor HC
Endocr Pract; 2000; 6(4):324-8. PubMed ID: 11242610
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin.
Mizuno H; Fujimoto S; Sugiyama Y; Kobayashi M; Ohro Y; Uchida S; Sasaki S; Togari H
Horm Res; 2003; 59(6):297-300. PubMed ID: 12784095
[TBL] [Abstract][Full Text] [Related]
3. Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature.
Jinnouchi T; Yoshimoto M; Ogino K; Oji T; Hayashi M
Intern Med; 2024 May; 63(10):1399-1404. PubMed ID: 37779064
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of polyuria in nephrogenic diabetes insipidus due to aquaporin-2 deficiency.
Hochberg Z; Even L; Danon A
Clin Endocrinol (Oxf); 1998 Jul; 49(1):39-44. PubMed ID: 9797845
[TBL] [Abstract][Full Text] [Related]
5. Triamterene in lithium-induced nephrogenic diabetes insipidus: a case report.
Inoue M; Nakai K; Mitsuiki K
CEN Case Rep; 2021 Feb; 10(1):64-68. PubMed ID: 32772236
[TBL] [Abstract][Full Text] [Related]
6. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride.
Kirchlechner V; Koller DY; Seidl R; Waldhauser F
Arch Dis Child; 1999 Jun; 80(6):548-52. PubMed ID: 10332005
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.
Mizuno H; Sugiyama Y; Ohro Y; Imamine H; Kobayashi M; Sasaki S; Uchida S; Togari H
Endocrine; 2004 Jun; 24(1):55-9. PubMed ID: 15249704
[TBL] [Abstract][Full Text] [Related]
8. Treatment of congenital nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride in an adult patient.
Konoshita T; Kuroda M; Kawane T; Koni I; Miyamori I; Tofuku Y; Mabuchi H; Takeda R
Horm Res; 2004; 61(2):63-7. PubMed ID: 14646392
[TBL] [Abstract][Full Text] [Related]
9. Effect of DDAVP on nocturnal enuresis in a patient with nephrogenic diabetes insipidus.
Jonat S; Santer R; Schneppenheim R; Obser T; Eggert P
Arch Dis Child; 1999 Jul; 81(1):57-9. PubMed ID: 10373137
[TBL] [Abstract][Full Text] [Related]
10. [The effect of hydrochrolothiazide on the patient of nephrogenic diabetes insipidus].
Ohta M; Sahata T; Mori T; Takeuchi K; Sugawara A; Arima S; Kikuya M; Ito S; Kimura T; Ota K
Nihon Naika Gakkai Zasshi; 2000 Nov; 89(11):2342-4. PubMed ID: 11142819
[No Abstract] [Full Text] [Related]
11. Nephrogenic diabetes insipidus induced by ureter obstruction due to benign prostatic hyperplasia: A case report.
Lou H; Shen Y; Xu Y; Zhang W; Ren Y
Medicine (Baltimore); 2020 Sep; 99(37):e22082. PubMed ID: 32925747
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic diabetes insipidus partially responsive to oral desmopressin in a subject with lithium-induced multiple endocrinopathy.
Kamath C; Govindan J; Premawardhana AD; Wood SJ; Adlan MA; Premawardhana LD
Clin Med (Lond); 2013 Aug; 13(4):407-10. PubMed ID: 23908517
[TBL] [Abstract][Full Text] [Related]
13. Lithium-induced nephrogenic diabetes insipidus after coronary artery bypass.
Leeman MF; Vuylsteke A; Ritchie AJ
Ann Thorac Surg; 2007 Aug; 84(2):656-7. PubMed ID: 17643658
[TBL] [Abstract][Full Text] [Related]
14. Desmopressin and indomethacin therapy for nephrogenic diabetes insipidus in patients receiving lithium carbonate.
Weinstock RS; Moses AM
South Med J; 1990 Dec; 83(12):1475-7. PubMed ID: 2123565
[TBL] [Abstract][Full Text] [Related]
15. A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man: differentiation from aquaporin-dependent nephrogenic diabetes insipidus by response of factor VII and von Willebrand factor to 1-diamino-8-arginine vasopressin administration.
Miyakoshi M; Kamoi K; Uchida S; Sasaki S
Endocr J; 2003 Dec; 50(6):809-14. PubMed ID: 14709855
[TBL] [Abstract][Full Text] [Related]
16. Desmopressin for nocturnal enuresis in nephrogenic diabetes insipidus.
Müller D; Marr N; Ankermann T; Eggert P; Deen PM
Lancet; 2002 Feb; 359(9305):495-7. PubMed ID: 11853799
[TBL] [Abstract][Full Text] [Related]
17. Transient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with lithium use.
Posner L; Mokrzycki MH
Am J Nephrol; 1996; 16(4):339-43. PubMed ID: 8739289
[TBL] [Abstract][Full Text] [Related]
18. Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
de Groot T; Sinke AP; Kortenoeven ML; Alsady M; Baumgarten R; Devuyst O; Loffing J; Wetzels JF; Deen PM
J Am Soc Nephrol; 2016 Jul; 27(7):2082-91. PubMed ID: 26574046
[TBL] [Abstract][Full Text] [Related]
19. Nephrogenic diabetes insipidus in a lethargic lithium-treated patient.
Meinardi JR; Donders SH
Neth J Med; 1997 Mar; 50(3):105-9. PubMed ID: 9121593
[TBL] [Abstract][Full Text] [Related]
20. Successful long-term treatment of congenital nephrogenic diabetes insipidus in a dog.
Takemura N
J Small Anim Pract; 1998 Dec; 39(12):592-4. PubMed ID: 9888114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
